Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia Read more
Sorrento And Mount Sinai To Jointly Develop COVI-SHIELD Antibody Therapy Targeting SARS-CoV-2 Infection (COVID-19) Read more
Novartis announces plan to initiate clinical trial of canakinumab for patients with COVID-19 pneumonia Read more
Gilead Announces Results From Phase 3 Trial of Investigational Antiviral Remdesivir in Patients With Severe COVID-19 Read more